Role of vitamin A supplementation in prevention of bronchopulmonary dysplasia in extremely low birth weight neonates: a systematic review of randomized trials

References

• Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 2008;358: 1700–1711.
   PubMed Web of Science ®Google Scholar
• Lee SK, Ye XY, Singhal N, et al. Higher altitude and risk of bronchopulmonary dysplasia among preterm infants. Am J Perinatol. 2013;30:601–606.
   PubMed Web of Science ®Google Scholar
• Shah PS, Sankaran K, Aziz K, et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol. 2012;32: 132–138.
   PubMed Web of Science ®Google Scholar
• Jobe AH. What is BPD in 2012 and what will BPD become? Early Hum Dev. 2012;88:S27–S28.
   PubMed Web of Science ®Google Scholar
• Vohr BR, Stephens BE, Higgins RD, et al. Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes. J Pediatr. 2012;161: 222–8.e3.
   PubMed Web of Science ®Google Scholar
• Natarajan G, Pappas A, Shankaran S, et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev. 2012;88:509–515.
   PubMed Web of Science ®Google Scholar
• Smith VC, Zupancic JAF, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004;144: 799–803.
   PubMed Web of Science ®Google Scholar
• Drysdale SB, Wilson T, Alcazar M, et al. Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax. 2011;66:468–473.
   PubMed Web of Science ®Google Scholar
• Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med. 2010;182:237–245.
   PubMed Web of Science ®Google Scholar
• Bhat R, Salas AA, Foster C, et al. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129:e682–e689.
   PubMed Web of Science ®Google Scholar
• Schlapbach LJ, Adams M, Proietti E, et al. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr. 2012;12:198.
   PubMed Web of Science ®Google Scholar
• Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116: 1353–1360.
   PubMed Web of Science ®Google Scholar
• Strueby L, Thébaud B. Advances in bronchopulmonary dysplasia. Expert Rev Respir Med. 2014;8:327–338.
   PubMed Web of Science ®Google Scholar
• Kim SB, Lee JH, Lee J, et al. The efficacy and safety of montelukast sodium in the prevention of bronchopulmonary dysplasia. Korean J Pediatr. 2015;58:347–353.
   PubMedGoogle Scholar
• Howlett A, Ohlsson A, Plakkal N. Inositol in preterm infants at risk for or having respiratory distress syndrome. Cochrane Database Syst Rev. 2015;2: CD000366.
   PubMed Web of Science ®Google Scholar
• Dargaville PA, Aiyappan A, De Paoli AG, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98:F122–F126.
   PubMed Web of Science ®Google Scholar
• Pierro M, Thébaud B, Soll R. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;11:CD011932.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2016;8:CD000501.
   Google Scholar
• Mactier H, Mokaya MM, Farrell L, et al. Vitamin A provision for preterm infants: are we meeting current guidelines? Arch Dis Child Fetal Neonatal Ed. 2011;96:F286–F289.
   PubMed Web of Science ®Google Scholar
• Biesalski HK, Nohr D. Importance of vitamin-A for lung function and development. Mol Aspects Med. 2003;24: 431–440.
   PubMed Web of Science ®Google Scholar
• Hughes AP, Shaw NJ, Southall P, et al. Conjunctival impression cytology in the preterm infant and it’s relation to outcome. Eur J Pediatr. 1997;156:471–475.
   PubMed Web of Science ®Google Scholar
• Shenai JP, Kennedy KA, Chytil F, et al. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr. 1987;111: 269–277.
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Wu TJ, Tyson JE, et al. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr. 2003;142:656–661.
   PubMed Web of Science ®Google Scholar
• Zachman RD, Samuels DP, Brand JM, et al. Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants. Am J Clin Nutr. 1996;63:123–129.
   PubMed Web of Science ®Google Scholar
• Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8:63–71.
   PubMedGoogle Scholar
• Mactier H, Weaver LT. Vitamin A and preterm infants: what we know, what we don’t know, and what we need to know. Arch Dis Child Fetal Neonatal Ed. 2005;90:F103–F108.
   PubMed Web of Science ®Google Scholar
• Metzler MD, Snyder JM. Retinoic acid differentially regulates expression of surfactant-associated proteins in human fetal lung. Endocrinology. 1993;133: 1990–1998.
   PubMed Web of Science ®Google Scholar
• Chytil F. The lungs and vitamin A. Am J Physiol. 1992;262:L517–L527.
   PubMed Web of Science ®Google Scholar
• Jefferies AL. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Paediatr Child Health. 2012;17:573–574.
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology. 2010;98:111–117.
   PubMed Web of Science ®Google Scholar
• Hasan SU, Potenziano J, Konduri GG, et al. Newborns Treated With Nitric Oxide (NEWNO) Trial Group. Effect of inhaled nitric oxide on survival without bronchopulmonary dysplasia in preterm infants: a randomized clinical trial. JAMA Pediatr. 2017;171:1081–1089.
   PubMed Web of Science ®Google Scholar
• Coutsoudis A, Adhikari M, Pillay K, et al. Effect of vitamin A supplementation on morbidity of low-birth-weight neonates. S Afr Med J. 2000;90:730–736.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration; 2011.
   Google Scholar
• Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340:1962–1968.
   PubMed Web of Science ®Google Scholar
• Wardle SP, Hughes A, Chen S, et al. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F9–FF13.
   PubMed Web of Science ®Google Scholar
• Meyer S, Gortner L, NeoVitaA Trial. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology. 2014;105: 182–188.
   PubMed Web of Science ®Google Scholar
• Rakshasbhuvankar A, Patole S, Simmer K, et al. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. BMC Pediatr. 2017;17:204.
   PubMed Web of Science ®Google Scholar
• Chabra S, Mayock DE, Zerzan J, et al. Vitamin A status after prophylactic intramuscular vitamin A supplementation in extremely low birth weight infants. Nutr Clin Pract. 2013;28:381–386.
   PubMed Web of Science ®Google Scholar
• Moreira A, Caskey M, Fonseca R, et al. Impact of providing vitamin A to the routine pulmonary care of extremely low birth weight infants. J Matern Fetal Neonatal Med. 2012;25:84–88.
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Tyson JE, Kennedy KA, et al. Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005;115:e249–e254.
   PubMed Web of Science ®Google Scholar
• Gadhia MM, Cutter GR, Abman SH, et al. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014;164:744–748.
   PubMed Web of Science ®Google Scholar
• Londhe VA, Nolen TL, Das A, et al. Neonatal Research Network. Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants. Am J Perinatol. 2013;30:771–780.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar